Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Multiple Myeloma × Nivolumab × Clear all

Phase

Phase 2 12 Phase 1 5 Phase 1/2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Melanoma 20 Carcinoma, Renal Cell 12 Stomach Neoplasms 8 Lung Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 5 Brain Neoplasms 5 Mesothelioma 4 Kidney Neoplasms 4 Carcinoma, Hepatocellular 4 Adenocarcinoma Of Esophagus 4 Urinary Bladder Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Various Advanced Cancer 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Mesothelioma, Malignant 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma 2 Anus Neoplasms 2 Adenocarcinoma 2 von Hippel-Lindau Disease 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Thoracic Neoplasms 1

Interventions

Dexamethasone 136 Bortezomib 77 Lenalidomide 74 Thalidomide 39 Melphalan 36 daratumumab 35 pomalidomide 30 Cyclophosphamide 29 Calcium Dobesilate 23 carfilzomib 20 Prednisone 18 Doxorubicin 13 elotuzumab 11 Filgrastim 11 ixazomib 10 isatuximab 9 Vincristine 9 belantamab mafodotin 8 Zoledronic Acid 8 Peripheral Blood Stem Cell Transplantation 8 dexamethasone acetate 7 Granulocyte Colony-Stimulating Factor 7 Epoetin Alfa 6 selinexor 5 Carmustine 5 fludarabine 4 Radiotherapy 4 Interferon-alpha 4 Etoposide 4 Cytarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02726581 2023-03-27

CheckMate 602

Bristol-Myers Squibb

Phase 3 Completed

170 enrolled 16 charts

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡